The 2026 SNMMI Annual Meeting, an international conference in the field of nuclear medicine and molecular imaging, was held at the Los Angeles Convention Center in Los Angeles, USA, from May 30 to June 2, 2026.

The details of the invited presentation are as follows:

INT04: New Concepts in Molecular Diagnosis and Treatment of Thyroid Disease May 30, 2026, 11:30 AM – 12:00 PM 408B (Convention Center)
Beyond Radioiodine: Novel Targeted Alpha Therapy with Astatine-211 for Thyroid Cancer
Tadashi Watabe, MD, PhD

CE24: Imaging & Dosimetry of Novel Radionuclides: Challenges & Opportunities　May 31, 2026, 5:20-5:35 PM 408A (Convention Center)
Imaging & Dosimetry of 211At-targeted Alpha Therapy: Insights from First-in-Human Studies in Thyroid and Prostate Cancer　　
Tadashi Watabe, MD, PhD　
　　　　　　　
ET03: Alpha 2- At211 and Pb212 (Non-CE)　June 1, 2026, 2:15 PM-3:30 PMPT
511ABC (Convention Center)
2:55 – 3:10 PM
At-211: Clinical Use
Tadashi Watabe, MD, PhD